v3.25.2
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance, common (in shares) at Mar. 31, 2022   97,163,701            
Beginning balance at Mar. 31, 2022 $ 516,215 $ 10 $ 100 $ (71) $ 745,661 $ (39,341) $ (191,788) $ 1,644
Beginning balance, preferred (in shares) at Mar. 31, 2022     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2022       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income 16,870           16,673 197
Foreign currency translation (2,386)         (2,604)   218
Stock-based compensation expense 31,245       31,245      
Shares issued:                
Exercise of stock options (in shares)   966,536            
Exercise of stock options 2,020       2,020      
Issuance of restricted shares and vesting of restricted units (in shares)   122,150            
Shares for acquisition of Fyber (in shares)   1,205,982            
Shares for acquisition of Fyber 50,000       50,000      
Payment of withholding taxes related to the net share settlement of equity awards (6,709)       (6,709)      
Ending balance, common (in shares) at Mar. 31, 2023   99,458,369            
Ending balance at Mar. 31, 2023 607,255 $ 10 $ 100 $ (71) 822,217 (41,945) (175,115) 2,059
Ending balance, preferred (in shares) at Mar. 31, 2023     100,000          
Ending balance, treasury (in shares) at Mar. 31, 2023       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income (420,448)           (420,228) (220)
Foreign currency translation (6,271)         (7,010)   739
Stock-based compensation expense 35,562       35,562      
Shares issued:                
Exercise of stock options (in shares)   1,050,553            
Exercise of stock options 2,871       2,871      
Issuance of restricted shares and vesting of restricted units (in shares)   1,610,010            
Acquisition of non-controlling interests in Fyber (3,751)       (1,173)     (2,578)
Payment of withholding taxes related to the net share settlement of equity awards $ (1,286)       (1,286)      
Ending balance, common (in shares) at Mar. 31, 2024 102,118,932 102,118,932            
Ending balance at Mar. 31, 2024 $ 213,932 $ 10 $ 100 $ (71) 858,191 (48,955) (595,343) 0
Ending balance, preferred (in shares) at Mar. 31, 2024 100,000   100,000          
Ending balance, treasury (in shares) at Mar. 31, 2024 758,125     758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net (loss) income $ (92,099)           (92,099)  
Foreign currency translation (2,349)         (2,349)    
Stock-based compensation expense $ 34,566       34,566      
Shares issued:                
Exercise of stock options (in shares) 95,318 93,799            
Exercise of stock options $ 373       373      
Issuance of restricted shares and vesting of restricted units (in shares)   3,764,911            
Payment of withholding taxes related to the net share settlement of equity awards $ (465)       (465)      
Ending balance, common (in shares) at Mar. 31, 2025 105,977,642 105,977,642            
Ending balance at Mar. 31, 2025 $ 153,958 $ 10 $ 100 $ (71) $ 892,665 $ (51,304) $ (687,442) $ 0
Ending balance, preferred (in shares) at Mar. 31, 2025 100,000   100,000          
Ending balance, treasury (in shares) at Mar. 31, 2025 758,125     758,125